Christopher Robinson: Immune Tolerance Breakdown In Pregnancy!
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“AJOG Expert Review: Immune tolerance breakdown in pregnancy: transplantation parallels in chronic intervillositis and villitis of unknown etiology – Schematic representation of immune dysregulation in villitis of unknown etiology (VUE)
The decidua and intervillous space exhibit a dominant infiltration of maternal CD8+ T cells, expressing the chemokine receptor CXCR3, alongside scattered histiocytes and CD4+ T cells. These CD8+ T cells target chorionic villi abnormally expressing polymorphic HLA molecules. The villous stroma is infiltrated by CD8+ T cells causing structural damage. Fetal Hofbauer cells become activated and express HLA class II molecules. The fetal endothelium also shows aberrant expression of polymorphic HLA. These findings are consistent with a T cell–mediated rejection (TCMR) phenotype.
Title: Immune tolerance breakdown in pregnancy: transplantation parallels in chronic intervillositis and villitis of unknown etiology
Authors: Pierre Hannoun, Alexandra Benachi, Marion Rabant, Cédric Usureau, Jean-Luc Taupin, Julien Zuber
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 17, 2026, 04:19WHO Raises Alarm Over Global Burden of Child Marriage
-
Apr 17, 2026, 04:11Sign Up for Our Latest BFS Insights Webinar – British Fertility Society
-
Apr 17, 2026, 03:43Chantelle Pereira: Endometriosis Paper Highlights Diagnostic Delays and Gaps in Patient Care
-
Apr 17, 2026, 03:35Tal Varsano: Plasma Proteomic Signature of the Human Menstrual Cycle
-
Apr 17, 2026, 03:30Vacancy for a Friendly Senior Embryologist in Berlin, Germany – ESHRE
-
Apr 17, 2026, 03:05Clinical Study Supports Continued IVF After Unsuccessful First Transfer – RBMO
-
Apr 17, 2026, 02:57Standing Together for Black Maternal Health Week – ACOG
-
Apr 16, 2026, 17:24No Difference Between Natural and Artificial Cycles in Endometrium Cases – RBMO
-
Apr 16, 2026, 17:20Marco Zaccaria: Recognizing Innovation in Adenomyosis Treatment